한약의 아토피피부염에 대한 국내외 동물실험 연구 동향: 최근 10년을 중심으로

키워드

참고문헌 (74)

1. Archer CB, "Atopic dermatitis", Medicine, 49(6), pp.370~373 (2021)
2. 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
3. "Adolescent Health Behavior Survey, Atopic dermatitis doctor diagnosis rate" (2022)[URL]
4. Schuler CF, "Novel insights into atopic dermatitis", J Allergy Clin Immunol, 151(5), pp.1145~1154 (2023)
5. Silverberg NB, "Inside out or outside in : does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?", Cutis, 96(6), pp.359~361 (2015)
6. Abraham A, "Topical steroid-damaged skin", Indian J Dermatol, 59(5), pp.456~459 (2014)
7. 이동훈, "아토피피부염 치료 실태에 관한 다기관 설문조사", Allergy Asthma & Respiratory Disease, 4(4), pp.271~275 (2016), 대한 소아알레르기 호흡기학회[DOI]
8. 강경화, "일개 대학병원 아토피피부염 환아의 병원 치료 및 대체보완요법 이용 양상과 치료비용", Allergy Asthma & Respiratory Disease, 22(1), pp.27~36 (2012), 대한 소아알레르기 호흡기학회[DOI]
9. "2015 Korean Treatment Guideline of Atopic Dermatitis"[URL]
10. 민들레, "아토피 피부염 외용제에 관련된 국내 임상 및 실험 논문 고찰", 대한한방소아과학회지, 27(1), pp.36~49 (2013), 대한한방소아과학회
11. 이문희, "한약재 단일 추출물 및 복합 추출물을 이용한 아토피성 피부염 억제 효과", 생명과학회지, 24(8), pp.851~859 (2014), 한국생명과학회
12. 이해진, "加味消風散이 염증 및 아토피피부염 동물병태에 미치는 영향", 동의생리병리학회지, 28(2), pp.146~153 (2014), 한의병리학회
13. Kim SR, "Oral administration of herbal mixture extract inhibits 2, 4-dinitrochlorobenzene-induced atopic dermatitis in BALB", c mice, 2014, pp.2014, 319438~
14. 김경진, "Ovalbumin으로 유발된 아토피피부염 모델 마우스에 대한 복합한약추출물 경구투여의 효과", 한방안이비인후피부과학회지, 27(3), pp.72~83 (2014), 대한한방안이비인후피부과학회
15. 승 윤 철, "아토피피부염을 유발한 마우스에서 청기해독탕의 항염증 효과", 디지털융복합연구, 12(8), pp.361~368 (2014), 한국디지털정책학회[DOI]
16. Park BK, "Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC", Nga murine model of atopic dermatitis, 2015, pp.13(165), 54~60
17. 정재훈, "급성 아토피 피부염 마우스 모델에서 한약조합약물의 염증반응 진정효과", 한방안이비인후피부과학회지, 28(1), pp.68~84 (2015), 대한한방안이비인후피부과학회[DOI]
18. Kong L, "BuShenYiQi granule inhibits atopic dermatitis via improving central and skin hypothalamic-pituitary-adrenal axis function", PLoS One, 10(2), pp.e0116427~ (2015)
19. 차호열, "황련-감초 추출물을 이용한 하태독법이 NC", Nga 생쥐에서 유발된 아토피 유사 피부염에 미치는 항염증 효과, 2015, pp.36(4), 486~497[DOI]
20. Cha HY, "Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC", Nga mice under high-fat diet conditions, 2016, pp.2016, 1739760~
21. Han HM, "Ameliorative effects of Artemisia argyi Folium extract on 2, 4‑dinitrochlorobenzene‑induced atopic dermatitis like lesions in BALB", c mice, 2016, pp.14(4), 3206~3214
22. Bae MJ, "Regulatory T Cell induced by Poria cocos Bark exert therapeutic effects in murine models of atopic dermatitis and food allergy", Mediators Inflamm, 2016, pp.3472608~ (2016)
23. Jung AR, "Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and IL-4, 2016, pp.16(1), 416~
24. 송지훈, "두시를 이용한 하태독법의 NC", Nga 생쥐에서 DNFB로 유발된 피부손상 완화 효과, 2016, pp.30(2), 109~115[DOI]
25. Yang JH, "Ethanol extract of Sanguisorbae Radix inhibits mast cell degranulation and suppresses 2, 4-Dinitrochlorobenzene-induced atopic dermatitis-like skin lesions", Mediators Inflamm, 2016, pp.2947390~ (2016)
26. Cha HY, "Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC", Nga mice, 2017, pp.206, 327~336
27. 류덕현, "DNCB로 유도된 아토피 피부염에 대한 당귀 추출물과 Bacillus polyfermenticus KJS-2의 효과", 대한한의학회지, 38(3), pp.30~42 (2017), 대한한의학회[DOI]
28. Ok S, "Effects of Angelica gigas Nakai as an anti-Inflammatory agent in in vitro and in vivo atopic dermatitis models", Evid Based Complement Alternat Med, 2018, pp.2450712~ (2018)
29. Yang JH, "Ethanolic extracts of Artemisia apiacea hance improved atopic dermatitis-like skin lesions in vivo and suppressed TNF-alpha", IFN-gamma⁻induced proinflammatory chemokine production in vitro, 2018, pp.10(7), 806~
30. Yang JH, "Jageum-Jung improves 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice and suppresses pro-inflammatory chemokine production by inhibiting TNF-α", IFN-γ-induced STAT-1and NFκB signaling in HaCaT cells, 2018, pp.221, 48~55
31. Sun Z, "Effect of Yupingfeng granules on the skin barrier in atopic dermatitis mice models", J Tradit Chin Med, 38(6), pp.872~878 (2018)
32. Fan HJ, "Effects and mechanism of action of Huang-lian-jie-du-tang in atopic dermatitis-like skin dysfunction in vivo and in vitro", J Ethnopharmacol, 240, pp.111937~ (2019)
33. 송대욱, "가미미후등식장탕이 DNCB 유도 아토피 피부염 동물모델에 미치는 효과", 대한한의학회지, 40(1), pp.63~77 (2019), 대한한의학회[DOI]
34. 손미주, "DNCB로 유발된 아토피 피부염 동물 모델에 대한 藿香正氣散 경구투여의 효과", 한방안이비인후피부과학회지, 32(2), pp.94~106 (2019), 대한한방안이비인후피부과학회[DOI]
35. Chen Y, "Huang-lian-jie-du extract ameliorates atopic dermatitis-like skin lesions induced by 2, 4-dinitrobenzene in mice via suppression of MAPKs and NF-κB pathways", J Ethnopharmacol, 249, pp.112367~ (2020)
36. Hwang YH, "Laminaria japonica Suppresses the Atopic Dermatitis-Like Responses in NC", Nga Mice and Inflamed HaCaT Keratinocytes via the Downregulation of STAT1, 2020, pp.12(11), 3238~
37. Xiong X, "Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3", MAPK, J Ethnopharmacol, pp.2021, 270[DOI]
38. Zeng HR, "A TCM formula VYAC ameliorates DNCB-induced atopic dermatitis via blocking mast cell degranulation and suppressing NF-κB pathway", J Ethnopharmacol, 280, pp.114454~ (2021)
39. Jung JA, "Safety evaluation of fermented Platycodon grandiflorus (Jacq.) A.DC. extract: genotoxicity, acute toxicity, and 13-week subchronic toxicity study in rats", J Ethnopharmacol, 275, pp.114138~ (2021)
40. Chen Y, "Anti-atopic dermatitis effects of dictamni cortex : Studies on in vitro and in vivo experimental models", Phytomedicine, 82, pp.153453~ (2021)
41. Wang L, "Efficacy and action mechanisms of a Chinese herbal formula on experimental models of atopic dermatitis", J Ethnopharmacol, 274, pp.114021~ (2021)
42. Song HK, "Alpinia officinarum water extract inhibits the atopic dermatitis-like responses in NC", Nga mice by regulation of inflammatory chemokine production, 2021, pp.144, 112322~
43. Song HK, "Spatholobus suberectus Dunn water extract ameliorates atopic dermatitis-like symptoms by suppressing proinflammatory chemokine production in vivo and in vitro", Front Pharmacol, 13, pp.919230~ (2022)
44. Huong Nguyen LT, "Effect of Sopoongsan on skin inflammation and hyperlocomotion in socially isolated mice with atopic dermatitis", Evid Based Complement Alternat Med, 2022, pp.3323201~ (2022)
45. Zhi W, "Ta-Xi-San suppresses atopic dermatitis involved in multitarget mechanism using experimental and network pharmacology analysis", Evid Based Complement Alternat Med, 2022, pp.8441938~ (2022)
46. Zeng H, "Viola yedoensis Makino formula alleviates DNCB-induced atopic dermatitis by activating JAK2", STAT3 signaling pathway and promoting M2 macrophages polarization, 2022, pp.103, 154228~
47. Park SH, "Gardenia jasminoides extract ameliorates DfE-induced atopic dermatitis in mice through restoration of barrier function and T-helper 2-mediated immune response", Biomed Pharmacother, 145, pp.112344~ (2022)
48. 장유미, "DNCB로 유도한 아토피 유사 피부염에 지모 추출물이 미치는 영향", 한국환경과학회지, 32(1), pp.67~76 (2023), 한국환경과학회[DOI]
49. Matsuoka H, "A mouse model of the atopic eczema", dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae, 2003, pp.58(2), 139~145
50. Dunnick CA, "Dermatology tactile learning tool : development and student evaluation of an interactive 3-dimensional skin lesion model for medical student education", J Am Acad Dermatol, 88(5), pp.1113~1115 (2023)
51. Thomsen SF, "Atopic dermatitis : natural history, diagnosis, and treatment", ISRN Allergy, 2014, pp.354250~ (2014)
52. Ständer S, "Atopic dermatitis", N Engl J Med, 384(12), pp.1136~1143 (2021)
53. Shi ZF, "The traditional Chinese medicine and relevant treatment for the efficacy and safety of atopic dermatitis : A systematic review and meta-analysis of randomized controlled trials", Evid Based Complement Alternat Med, 2017, pp.6026434~ (2017)
54. Martel BC, "Translational animal models of atopic dermatitis for preclinical studies", Yale J Biol Med, 90(3), pp.389~402 (2017)
55. Kyoung-Sun Lee, "A Novel Model for Human Atopic Dermatitis: Application of Repeated DNCB Patch in BALB", c Mice, in Comparison with NC, Laboratory Animal Research, pp.2010, 26(1)[DOI]
56. Man MQ, "Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis : structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges", J Invest Dermatol, 128(1), pp.79~86 (2008)
57. Platts-Mills T, "Immunology", pp.323~343 (2001), Gower medical publishing
58. 나혜연, "2세 이하 영유아 중증 아토피피부염에서의 항원 감작", Allergy Asthma & Respiratory Disease, 19(2), pp.146~154 (2009), 대한 소아알레르기 호흡기학회
59. 조나영, "Identification of Allergens of Dermatophagoides farinae on Canine Atopic Dermatitis in Korea", 한국임상수의학회지, 31(6), pp.490~494 (2014), 한국임상수의학회
60. Kim JY, "Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC", Nga mice, 2014, pp.23(1), 53~57
61. Hopkins JE, "Selective haptenation of cellular or extracellular protein by chemical allergens : association with cytokine polarization", Chem Res Toxicol, 18(2), pp.375~381 (2005)
62. Hwang BM, "Decursin inhibits UVB-induced MMP expression in human dermal fibroblasts via regulation of nuclear factor-κB", Int J Mol Med, 31(2), pp.477~483 (2013)
63. 강재선, "참당귀(Angelica gigas Nakai) 유래 decursin, decursinol 그리고 decursinol angelate의 약리 효과", 생명과학회지, 31(12), pp.1128~1141 (2021), 한국생명과학회[DOI]
64. Kim JH, "Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages", Mol Pharmacol, 69(6), pp.1783~1790 (2006)
65. National Korean Medicine University Joint Textbook Compilation Committee, "Herbology", pp.225~226 (2016), Younglim Co
66. 박정숙, "백선피의 iNOS발현과 염증성사이토카인의 생성에 미치는 영향", 생약학회지, 42(4), pp.348~353 (2011), 한국생약학회
67. Jo JJ, "Gup Yu Bang", pp.44~ (1998), Yeo kang publishing Co
68. 안상현, "황련감초 하태독법의 피부 지방장벽형성 증진효과", 대한한방소아과학회지, 31(3), pp.14~23 (2017), 대한한방소아과학회
69. Nam BS, "A clinical study on atopic dermatitis", J Korean Oriental Med, 21(4), pp.204~215 (2000)
70. Limandjaja GC, "Increased epidermal thickness and abnormal epidermal differentiation in keloid scars", Br J Dermatol, 176(1), pp.116~126 (2017)
71. Eichenfield LF, "Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis", J Am Acad Dermatol, 70(2), pp.338~351 (2014)
72. Yang TB, "Pruritus in allergy and immunology", J Allergy Clin Immunol, 144(2), pp.353~360 (2019)
73. Gelmetti C, "The value of SCORAD and beyond. Towards a standardized evaluation of severity?", Allergy, 59(78), pp.61~65 (2004)
74. Charman C, "Measuring atopic dermatitis severity in randomized controlled clinical trials : what exactly are we measuring?", J Invest Dermatol, 120(6), pp.932~941 (2003)

관련 논문AI추천